Therapeutic Starvation And Autophagy In Prostate Cancer: A New Paradigm For Targeting Metabolism In Cancer Therapy

Main Category: Prostate / Prostate Cancer
Also Included In: Urology / Nephrology;  Cancer / Oncology
Article Date: 27 Oct 2008 - 1:00 PDT

email to a friend   printer friendly   opinions  

UroToday.com - In the online edition of The Prostate, Robert S. DiPaola and co-investigators reported their research on autophagy. Autophagy is a mechanism of cellular resistance or alternatively cell death. Cancer metabolism differs from normal cells in that it uses anaerobic glycolysis as opposed to oxidative phosphorylation to metabolize glucose. With nutrient deprivation, a cell response to starvation occurs whereby cellular organelles and bulk cytoplasm are targeted to lysosomes for degradation to supply an alternate energy source. Sustained autophagy under conditions of protracted cellular starvation is proposed to lead to cell death, thereby the survival or death consequences of autophagy are condition-dependent. Autophagy is proposed to be impaired in prostate cancer (CaP) due to activation of mTOR, which inhibits autophagy or through allelic loss of the essential autophagy gene beclin1. In this research, the effect of a prototypical inhibitor of glycolysis, 2DG, a glucose analogue that inhibits glucose uptake was assessed to determine if 2DG induces cytotoxicity and autophagy in CaP cells.

LNCaP and PC3 cells were treated with increasing concentrations of 2DG and their growth was inhibited in a dose dependent fashion. Using time-lapse microscopy, growth was decreased more by therapeutic starvation over time. Markers of cell cycle checkpoint proteins were decreased, thus supporting these observations. Expression of the fluorescent autophagy marker GFP-LC3 in the LNCaP and PC3 cells was performed with or without modulation of the expression of the autophagy regulator Beclin1 using siRNA. 2DG induced Beclin1 dependent autophagy in both cell lines, and knockdown of beclin1 abrogated 2DG-induced autophagy. To determine the effect of Beclin1 on apoptotic proteins such as caspase-3, the effect of 2DG on the cleaved (activated) fragment of caspase-3 was assessed. Caspase-3 was cleaved to the active fragment in cells treated with 2DG. Addition of Beclin1 siRNA, which abrogates autophagy, permitted increased activation of caspase-3 at lower 2DG concentrations. This suggests that under these conditions, Beclin1 and autophagy were associated with resistance to apoptosis. These data suggest autophagy is a mechanism of resistance to 2DG-induced cytotoxicity.

The researchers also developed a tissue microarray system to assess Beclin1 using digitized image analysis. This system permits more standardized assessment of autophagy in tissue samples and for example, may prove useful in clinical trials of agents that target glycolysis to induce cytotoxicity.

Dipaola RS, Dvorzhinski D, Thalasila A, Garikapaty V, Doram D, May M, Bray K, Mathew R, Beaudoin B, Karp C, Stein M, Foran DJ, White E
Prostate. 2008 Sep 2. (Epub ahead of print)
doi:10.1002/pros.20837

Written by UroToday.com Contributing Editor Christopher P. Evans, MD, FACS

UroToday - the only urology website with original content written by global urology key opinion leaders actively engaged in clinical practice.

To access the latest urology news releases from UroToday, go to: www.urotoday.com

Copyright © 2008 - UroToday

• Additional
• References
• Citations